Newsroom News Archive Publications Contact Us for Experts
Media Contacts
Olivia Fermano
W: (215) 349-5653

Related Links

Recommend Story
> Epigenetics Shapes Fate of Brain vs. Brawn Castes in Carpenter Ants
> Molecular Master Switch for Pancreatic Cancer Identified, Potential Predictor of Treatment Outcome
> Eat to Dream: Penn Study Shows Dietary Nutrients Associated with Certain Sleep Patterns
  All News Releases
    Media Resources
spacerINVITATION TO COVERspacer Print Version
October 29, 2007

PENN Medicine Media Seminar Series


Frontiers in Cancer Research, Treatment & Resources




Moderator:  Craig B. Thompson, MD,
Director of the Abramson Cancer Center of the University of Pennsylvania.

“Fetching” New Approaches to Cancer Treatment: Penn’s School of Medicine & School of Veterinary Medicine are Enlisting “Man’s Best Friend” in the Fight Against Cancer

Robert Vonderheide, MD, Assistant Professor of Medicine, Hematology/Oncology from Penn’s School of Medicine and Karin Sorenmo, DVM, Chief, Oncology Section, Matthew J. Ryan Veterinary Hospital’s and Associate Professor of Oncology at Penn’s School of Veterinary Medicine, will present data on their success using an immunotherapy vaccine to treat lymphoma in pet dogs – and hopefully someday in humans as well.

Special Guest:  Lymphoma patient and clinical trial participant Kyra the Rhodesian Ridgeback and her humans Eileen and Brian Eisenhower.

Trans-oral Robotic Surgery
World’s First Robotic Procedures to Treat Head & Neck Cancers
For patients with cancer of the mouth and throat, surgery is a frequent course of treatment, often leading to speech and swallowing dysfunction and external scarring and disfigurement. Bert O’Malley, Jr. MD, Gabriel Tucker and Chair of Penn’s Department of Otorhinolaryngology/Head and Neck Surgery and Gregory S. Weinstein, MD, Vice Chair of Otorhinolaryngology/Head & Neck Surgery and Co-Director of the Center for Head & Neck Cancer, have recently completed a study – the most comprehensive and largest to date – that demonstrates the effective use of the daVinci Surgical Robotic System® to perform Trans-Oral Robotic Surgery (TORS). Use of the robot greatly reduces surgical trauma for patients without compromising positive treatment outcomes.

Penn Fertility Care and The Oncofertility Consortium
Preserving the Life of Cancer Patients – Now and for Generations to Come
Clarissa Gracia, MD, Assistant Professor of Obstetrics & Gynecology and  reproductive endocrinologist, will discuss her work and research in the field of oncofertility which seeks to find the most effective ways to preserve fertility in cancer patients and survivors. Dr. Gracia and her colleagues are working to find improved and effective fertility preservations options for female cancer patients. Penn Fertility care is one of only 5 institutions in the U.S. recently designated as an official inaugural member of the national Oncofertility Consortium which was awarded a $21 million grant from the NIH.

Cancer & the Web: Providing Patient Resources

Penn radiation oncologist James M, Metz, MD, is the Editor-in-Chief of OncoLink, Penn’s award-winning cancer resource – the oldest (founded in 1994), largest, and one of the most trusted sources of cancer information on the Internet. Dr. Metz will present an overview of patient-oriented cancer web sites to reveal how and where both the media and consumers can get comprehensive information about specific types of cancer, updates on cancer treatments, and news about research advances.



The University of Pennsylvania School of Veterinary Medicine

The Hill Pavilion – Allam Room
380 S. University Ave.  (Entrance on 38th Street) Phila, PA  19104

November 8, 2007
Noon – 1:30 p.m.

Lunch will be served.

FREE Parking is available at the Matthew J. Ryan Veterinary Hospital, 39th & Spruce Sts.

To learn more about the Abramson Cancer Center of the University of Philadelphia, visit

To learn more about OncoLink, visit

To read more about , click here.

# # #

PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is currently ranked #3 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals — its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center — a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2016, The Trustees of the University of Pennsylvania